# Hybrid VMAT-3DCRT as Breast Treatment Improvement Tool

## TL;DR

This paper proposes a hybrid radiotherapy technique combining 3DCRT and arctherapy to improve breast cancer treatment by optimizing tumor coverage and organ preservation, with tailored application based on patient characteristics.

## Contribution

It introduces a hybrid approach that leverages the robustness of 3DCRT and the precision of arctherapy, offering a customizable treatment option for breast cancer patients.

## Key findings

- Hybrid approach is effective for certain patient profiles.
- Statistical analysis supports tailored application based on patient characteristics.
- Potential to improve treatment outcomes and reduce side effects.

## Abstract

Radiation therapy is an important tool in the treatment of breast cancer and can play a crucial role in improving patient outcomes. For breast cancer, if the technique has been for a long time the use of 3DCRT, clinicians have seen the management evolve greatly in recent years. Field-in-field and IMRT approaches and more recently dynamic arctherapy are increasingly present. All of these approaches are constantly trying to improve tumour coverage and to preserve organs at risk by minimising the doses delivered to them. If arctherapy allows a considerable reduction of high doses received by healthy tissues, no one can deny that it also leads to an increase of low doses in tissues that would not have received any with other techniques. It is with this in mind that we propose a hybrid approach combining the robustness of the 3DCRT approach and the high technicality and efficiency of arctherapy. Statistical tests allow us to draw conclusions about the possibility of using the hybrid approach in certain cases (right breast, BMI > 23, age > 48, target volume >350cc, etc.). Indeed, depending on the breast laterality and patients morphological characteristics, hybridization may prove to be a therapeutic tool of choice in the management of breast cancer in radiotherapy. a)